Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich’s Ataxia
Condition(s):Friedreich’s AtaxiaLast Updated:May 1, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Friedreich’s AtaxiaLast Updated:May 1, 2018Completed
Condition(s):Friedreich AtaxiaLast Updated:April 13, 2021Completed
Condition(s):Friedreich’s AtaxiaLast Updated:May 18, 2018Completed
Condition(s):Retinal Disease; Macular DiseaseLast Updated:January 30, 2024Completed
Condition(s):OsteopetrosisLast Updated:October 11, 2023Completed
Condition(s):CandidemiaLast Updated:November 3, 2023Recruiting
Condition(s):Anterior Uveitis; UveitisLast Updated:October 8, 2012Completed
Condition(s):Friedreich’s AtaxiaLast Updated:December 8, 2017Completed
Condition(s):Adverse Effects in the Therapeutic Use of InterferonLast Updated:August 28, 2013Unknown status
Condition(s):Inherited Ophthalmic Diseases; Inherited Retinal DegenerationLast Updated:August 13, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.